Big Gain For Unicycive Therapeutics Inc.
Wed, Aug 14, 2024 at 07:13 PM
Unicycive Therapeutics Inc. (UNCY:NASDAQ) rocketted at $0.32, a gain of 34%. The stock appeared on our News Catalysts scanner on Wed, Aug 14, 2024 at 10:47 AM in the 'INVESTOR UPDATE' category. From Wed, Jul 31, 2024, the stock recorded 30.00% Up Days and 18.18% Green Days
About Unicycive Therapeutics Inc. (UNCY:NASDAQ)
Unicycive Therapeutics Inc is a biotechnology company dedicated towards developing treatments for certain medical conditions. It is focusing on kidney diseases.
Top 10 Gainers:
- Kubient Inc. (KBNT:NASDAQ), 100%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 100%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 81.89%
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 67.83%
- Digital Ally, Inc. (DGLY:NASDAQ), 61.73%
- Knightscope Inc. (KSCP:NASDAQ), 52.11%
- Reborn Coffee Inc. (REBN:NASDAQ), 35.36%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 35.16%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 34.03%
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 33.4%